Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma

This study has been completed.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Dental and Craniofacial Research (NIDCR) ) Identifier:
First received: September 3, 2010
Last updated: November 10, 2015
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2015
  Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)